VOYA INVESTMENT MANAGEMENT LLC - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 211 filers reported holding DENALI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 4.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,270,552
-29.8%
255,480
+0.4%
0.01%
-22.2%
Q2 2023$7,506,488
+76.3%
254,371
+37.6%
0.01%
+80.0%
Q1 2023$4,258,944
-6.0%
184,850
+13.4%
0.01%
-16.7%
Q4 2022$4,532,919
-7.1%
162,996
+2.6%
0.01%
-14.3%
Q3 2022$4,877,930
-28.2%
158,942
-31.1%
0.01%
-58.8%
Q2 2022$6,793,000
+61.2%
230,830
+76.2%
0.02%
+88.9%
Q1 2022$4,215,000
+169.5%
130,982
+273.5%
0.01%
+200.0%
Q4 2021$1,564,000
-12.9%
35,073
-1.5%
0.00%
-25.0%
Q3 2021$1,796,000
-36.0%
35,591
-0.5%
0.00%
-20.0%
Q2 2021$2,805,000
+78.2%
35,765
+29.7%
0.01%
+66.7%
Q1 2021$1,574,000
-31.3%
27,573
+0.8%
0.00%
-40.0%
Q4 2020$2,291,000
+192.2%
27,350
+25.0%
0.01%
+150.0%
Q3 2020$784,000
+48.2%
21,8820.0%0.00%
+100.0%
Q2 2020$529,000
+20.5%
21,882
-12.8%
0.00%0.0%
Q1 2020$439,000
+8.1%
25,085
+7.7%
0.00%0.0%
Q4 2019$406,000
+36.2%
23,297
+19.9%
0.00%0.0%
Q3 2019$298,000
-26.1%
19,4300.0%0.00%0.0%
Q2 2019$403,000
-6.7%
19,430
+4.5%
0.00%0.0%
Q1 2019$432,000
+12.5%
18,6010.0%0.00%0.0%
Q4 2018$384,000
+5.2%
18,601
+10.7%
0.00%0.0%
Q3 2018$365,00016,7980.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Crestline Management, LP 7,460,732$240,012,00028.78%
Casdin Capital, LLC 1,500,000$48,255,0002.16%
Flagship Pioneering Inc. 2,619,968$84,284,0001.98%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 38,000$8,192,0001.85%
Yiheng Capital Management, L.P. 1,014,684$32,642,0001.49%
SECTORAL ASSET MANAGEMENT INC 207,100$6,662,0001.18%
Artal Group S.A. 600,000$19,302,0000.81%
GILDER GAGNON HOWE & CO LLC 2,619,217$84,260,0000.78%
Temasek Holdings (Private) Ltd 5,369,487$172,736,3970.73%
BRANDYWINE MANAGERS, LLC 9,601$309,0000.53%
View complete list of DENALI THERAPEUTICS INC shareholders